Navigation Links
CAP Technology is Being Applied to Isolation/Containment Applications Worldwide

Williamsville, NY (PRWEB) December 19, 2013

Isolation Sciences' Continuous Access Port technology was recently developed to lower energy costs in laboratory fume hoods by reducing over 80 percent of the amount of conditioned laboratory air that must be drawn into the fume hood and exhausted outdoors to meet safety guidelines. This technology is now being used in other energy industries around the world.

CAP Technology offers movable access ports in an isolation or containment enclosure, which allow for continuous freedom of movement and unobstructed access to the interior of a containment enclosure, while maintaining the isolation capability of the enclosure. The CAP technology was first applied to laboratory fume hoods to reduce the over $5 billion of wasted energy by using a fume hood with an open sash. Now the CAP technology is being applied to other applications globally, including chemical manufacturers in Western Australia, pharmaceutical isolation enclosures in the U.S. and Japan and chemical equipment washing stations in Macedonia.

Pointed CAP technology consists of having mobile ports in a flexible barrier film to allow non-obstructive and continuous access an isolation barrier and maintain full isolation capability. CAP technology has been integrated into other applications:

-JohDec Eng. (Western Australia) fabricated a custom containment enclosure using the CAP technology to provide continuous access to the interior of the enclosure.

-Pharmaceutical Containment Technologies (US) provides additional containment in a laboratory isolation enclosure with unobstructed access into the enclosure with two movable glove ports.

-Johnson Matthey (Macedonia) fabricated a high-pressure jet equipment cleaning chamber using the CAP technology to provide continuous access to the interior of the cabinet to manipulate the liquid cleaning jet applicator.

CAP technology has many applications with which one needs to reach through a physical isolation barrier within a containment enclosure, to have continuous movement of their arms and have continuous access to operate with movable ports, and to maintain enclosure isolation/containment.

Find out more about what Isolation Sciences LLC does and how their CAP technology can be applied by visiting

About the Company:
Isolation Sciences LLC is an innovation leader in providing value added, practical energy management products to realize savings in commercial laboratory energy consumption and isolation/containment risk management solutions to protect individuals against airborne chemical and biological vapors and aerosols that are hazardous to human health. The company’s patented Continuous Access Port [CAP] concept provides practical and cost-efficient air containment solutions to meet energy and risk management needs in the commercial, academic and medical markets. For more information, visit Isolation Sciences’ website at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Tennessee Optometrist Dr. John Pino Offers Multi-Prong Treatment Involving Technology and Nutrition to Low Vision Patients with AMD and Other Vision Conditions
2. Draper Mobile Technology Could Aid War on Obesity
3. California and New York Students Capture $100,000 Scholarship Prizes in 2013 Siemens Competition in Math, Science & Technology
4. BCC Research: Latest in Biotechnology Market Research
5. New Monol Oligomer Technology Expands Applications for Cray Valley’s Krasol Additives
6. Ancon Technologies New Cancer Screening Technology Will Help Defeat Cancer
7. Introducing a Personal Injury Chiropractor in Tampa Florida That is Utilizing the Latest Treatment Technology in the Industry, Courtesy of Elan Wellness Center
8. Phoenix Research Labs Partners with Voxeleron to Advance Technology for Eye Research
9. Kerr’s SonicFill Composite System Wins Pride Institute “Best of Class” Technology Award for Third Consecutive Year
10. Patient-Centric Technology for Better Trial Outcomes, a New and Upcoming Clinical Trial Webinar Hosted by Xtalks
11. Dr. Yamo Deniz to Join Cytos Biotechnologys Board of Directors
Post Your Comments:
(Date:11/24/2015)... 24, 2015 Halozyme Therapeutics, Inc. (NASDAQ: HALO ) ... New York on Wednesday, December 2 at 9:30 ... president and CEO, will provide a corporate overview. th ... at 1:00 p.m. ET/10:00 a.m. PT . Jim ... provide a corporate overview. --> th Annual Oppenheimer ...
(Date:11/24/2015)... ... November 24, 2015 , ... Copper is an essential ... bound to proteins, copper is also toxic to cells. With a $1.3 million ... (WPI) will conduct a systematic study of copper in the bacteria Pseudomonas aeruginosa ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
Breaking Biology Technology:
(Date:11/12/2015)... CAMBRIDGE, Mass. , Nov. 12, 2015 /PRNewswire/ ... Broad Institute of MIT and Harvard for use ... chemical discovery information management tools. The partnership will ... share both biological and chemical research information internally ... tools will be used for managing the Institute,s ...
(Date:11/10/2015)... YORK , Nov. 10, 2015 ... to behavioral biometrics that helps to identify and ... fraud. Signature is considered as the secure and ... the identification of a particular individual because each ... more accurate results especially when dynamic signature of ...
(Date:11/2/2015)... MENLO PARK, Calif. , Nov. 2, 2015 /PRNewswire/ ... to $9 million to provide preclinical development services to ... Under the contract, SRI will provide scientific expertise, modern ... a wide variety of preclinical pharmacology and toxicology studies ... --> --> The PREVENT Cancer Drug ...
Breaking Biology News(10 mins):